Minireviews
Copyright ©The Author(s) 2022.
World J Cardiol. Jul 26, 2022; 14(7): 392-402
Published online Jul 26, 2022. doi: 10.4330/wjc.v14.i7.392
Table 1 It shows data on incidences of acute, chronic heart failure, and acute heart failure
Ref.
Study type
Country of origin
Incidences
Zhou et al[6], 2020 Retrospective cohort studyChinaTotal patients 191. deceased 54 patients (28 had chronic hf exacerbation, i.e., 52%) survived 137 patients (16 had chronic hf exacerbation, i.e., 12%) P < 0.0001
Arentz et al[7], 2020 Case seriesUnited statesTotal patients 21. nine patients (42.9%) acute on chronic hf
Ruan et al[8], 2020 Multicenter retrospective analysisChinaTotal patients 150. death 68 acute on chronic hf 5 (7%)
Shis et al[9], 2020 Single-center cohort jan 2020 - feb 2020ChinaTotal patients 416. new-onset heart failure 4.1%
Chen et al[12], 2020 Retrospective studyChinaTotal patients 274. acute on chronic hf 1 (< 1%) new-onset hf 21 (7.7%). 1 recovered and 20 died
Inciardi et al[13], 2020 Retrospective studyItalyTotal patients 99. acute on chronic hf 21 (21%)
Table 2 A late complication in subacute and chronic recovery phases
Diagnostic tools
Likely heart failure
Likely COVID/ARDS
BNP/NT-Pro BNP and clinical findingsBNP > 100 pg/mL or NT-Pro BNP > 450 pg/mL Signs and symptoms of right and left heart failure< 450 pg/mL Absence of signs and symptoms of volume overload
EKGAbnormal ekg findings of LVH, LAE, Sinus tachycardia, LAD, RAD, AF, PVCs, BBBNonspecific findings or symptoms of pulmonary embolism, Right heart strain or myocardial ischemia
ECHOEjection Fraction%, RV dilatation and dysfunction, LV Diastolic dysfunction, LV global systolic dysfunctionFindings of pulmonary arterial hypertension; RV dysfunction, enlargement and abnormal contraction, septal dyskinesia. Acute Cor pulmonale
CMRIEstablishes ischemic vs nonischemic heart failure, quantification of ventricular function and scar burdenDistinguishes pulmonary vs extrapulmonary causes for acute respiratory distress syndrome
Table 3 Summary of management
Management of heart failure
We should know that the development of heart failure in COVID-19 patients can complicate management and worsen the prognosis; Chronic heart failure patients have adverse outcomes compared to new-onset heart failure patients; GDMT guided medical therapy should be used in heart failure with individualized patient decision making based on hemodynamic status and development of complications; Avoiding over diuresis to prevent kidney injury and hypoperfusion is necessary; Watching for signs of deterioration and shock with early initiation of vasopressors in mixed shock should be practiced; Cardiac arrhythmias and acute myocardial infarction are some major complications to look out for.; Advanced hemodynamic monitoring helps to guide management in these patients; Post-recovery cardiac, pulmonary rehabilitation with psychological support and nutritional interventions is necessary